English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
新股上市 心泰医疗(2291.HK)今日于港交所上市 暗盘收涨2.23%
Nov 08, 2022 08:56 HKT
新股上市 心泰醫療(2291.HK)今日於港交所上市 暗盤收漲2.23%
Nov 08, 2022 08:55 HKT
Sirnaomics已完成STP705用于成人腹部减脂医学美容治疗的首例受试者给药
Nov 08, 2022 08:45 HKT
Sirnaomics已完成STP705用於成人腹部減脂醫學美容治療的首例受試者給藥
Nov 08, 2022 08:44 HKT
Sirnaomics Doses the First Patient in Phase I Clinical Trial of RNAi Therapeutic STP705 in Adults Undergoing Abdominoplasty for Medical Aesthetics Treatment
Nov 08, 2022 08:43 HKT
Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX
Nov 07, 2022 15:49 HKT
中国抗体宣布委任王善春先生为中国区总裁
Nov 04, 2022 17:49 HKT
中國抗體宣佈委任王善春先生為中國區總裁
Nov 04, 2022 17:48 HKT
SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company
Nov 04, 2022 17:47 HKT
研发实力强劲业绩增长亮眼 百奥赛图捷报频传未来可期
Nov 03, 2022 14:33 HKT
研發實力強勁業績增長亮眼 百奧賽圖捷報頻傳未來可期
Nov 03, 2022 14:32 HKT
Led by Legend Capital, Easy-Flow Raises Tens of Millions of CNY in Angel Round
Nov 01, 2022 17:51 HKT
Avance Clinical赞助全球Scrip奖项的中国生物制药奖
Oct 27, 2022 08:00 HKT
Avance Clinical贊助全球Scrip獎項的中國生物製藥獎
Oct 27, 2022 08:00 HKT
중국에서의 임상 연구 기회와 미국 식품의약국 승인 경로 – 백서
Oct 27, 2022 07:00 HKT
Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE
Oct 26, 2022 19:00 HKT
巨子生物已进入招股阶段:中国皮肤护理领军企业 年利润超8亿
Oct 26, 2022 12:32 HKT
巨子生物已進入招股階段:中國皮膚護理領軍企業 年利潤超8億
Oct 26, 2022 12:31 HKT
Giant Biogene has Entered Offering Stage: China's Leading Skin Treatment Company with Annual Profits of More Than RMB800 Million
Oct 26, 2022 12:30 HKT
中国的临床研究机会和美国食品药品监督管理局批准的途径 - 白皮书
Oct 26, 2022 07:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: